Nanoengineered Niclosamide as a Microenvironment Modulator for Spinal Cord Regeneration: A Hypothetical Roadmap Toward Brain/Head Transplant Feasibility

Restoring long-distance spinal cord connectivity remains a major challenge in regenerative medicine. Despite advances in stem cell therapy, biomaterial scaffolds, and neuromodulation, recovery after spinal cord injury (SCI) is limited by a hostile post-injury microenvironment marked by chronic inflammation, glial scarring, and extracellular matrix (ECM) stiffening. This Perspective proposes nanoengineered niclosamide, a repurposable multi-pathway modulator, as a strategy to reprogram this niche. By attenuating NF-κB/STAT3-driven inflammation, suppressing fibrotic signaling, and reducing ECM rigidity, nanoengineered niclosamide may synergize with scaffold- and stimulation-based approaches, highlighting microenvironmental modulation as a realistic path forward for SCI repair.